Rebiotix
Rebiotix Inc., a subsidiary of Ferring Pharmaceuticals, is a pioneering company based in Roseville, Minnesota, dedicated to harnessing the power of the microbiome to address debilitating diseases. With a strong focus on microbiome-based technologies, Rebiotix has achieved significant milestones, including FDA approval of a first-in-class live biotherapeutic product for preventing C. difficile infection recurrence.
As a global leader in microbiome-based therapeutics and research, Rebiotix, in collaboration with Ferring Pharmaceuticals, is committed to improving the lives of individuals worldwide. Through innovative technologies and a passion for microbiome research, the company aims to tackle some of the most pressing healthcare challenges of our time.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.